The Bovine Plasma Market, estimated at USD 961.6 Mn in 2025, is expected to exhibit a CAGR of 5.8% and reach USD 1,426.9 Mn by 2032.
The market growth is fueled by rising demand for advanced biotechnology solutions that improve healthcare outcomes, along with increasing adoption in areas such as drug development, diagnostics, and personalized medicine. Innovations in genomics, cell and gene therapies, and biomanufacturing, supported by strong R&D investments, are enhancing treatment effectiveness, efficiency, and accessibility. Furthermore, favorable regulatory support, strategic collaborations, and the growing focus on precision medicine are accelerating market expansion and opening new opportunities for industry participants.
Bovine serum is preferred standard for protein assay. Protein assay are standards to determine the quantity of other proteins present in a sample. Bovine serum albumin (BSA) is a globular protein that is often used as a protein concentration standard in lab experiments as well as in numerous other biochemical applications. It is very useful in different biochemical and life science applications because of its lack of effect in many different biochemical reactions as it does not affect other enzymes. Another useful aspect of bovine serum include that it is small in size and can be easily stored. It is stable at room temperature for up to three weeks.
Global Bovine Plasma Market– Impact of Coronavirus (COVID-19) Pandemic
The COVID-19 pandemic and lockdowns in various countries across the globe have impacted the financial status of businesses across all sectors, including the private healthcare sector. The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry, mainly due to strict lockdown in several regions. Private healthcare is one such sector that has been impacted significantly by the COVID-19 pandemic.
However, the COVID-19 pandemic had a positive impact on the bovine plasma market, owing to the increasing efforts by the key players in the market to develop vaccines for COVID-19 infection. For instance, on June 5, 2025, an article published in American Association for the Advancement of Science, it is found that cow’s antibody can help in neutralization of coronavirus. Cows are excellent factories for producing antibodies, and not simply because they have more blood than smaller animals designed to produce human-like proteins. Their blood can also contain twice as many antibodies per milliliter as human blood.
Thus, increasing efforts by the key players to develop vaccines and carry research and development activities for COVID-19 infection is expected to drive the market growth over the forecast period.
Global Bovine Plasma Market: Key Developments
Bovine plasma is used in forensic research for sample preparation and storage considerations, which is expected to drive the global bovine plasma market growth over the forecast period. For instance, in March 2025, according to the National Center for Biotechnology Information, the whole mammalian blood sources are often used for forensic research and training when human samples cannot be sourced. Bovine, porcine, and equine blood have shown to be viable alternatives to whole human blood for forensic purposes.
The increasing adoption of growth strategies by market players is expected to drive the growth of global bovine market over the forecast period. For instance, on October 27, 2025 Abcam, a global innovator of life science reagents and tools announced the acquisition of BioVision, a company which is engaged in providing tools for drug discovery and biological researches.